RNase MCPIP1 regulates hepatic peroxisome proliferator-activated receptor gamma via TXNIP/PGC-1 alpha pathway

被引:10
|
作者
Pydyn, Natalia [1 ]
Kadluczka, Justyna [1 ]
Kus, Edyta [2 ]
Pospiech, Ewelina [3 ]
Losko, Magdalena [1 ]
Fu, Mingui [4 ]
Jura, Jolanta [1 ]
Kotlinowski, Jerzy [1 ]
机构
[1] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Gen Biochem, Gronostajowa 7, PL-30387 Krakow, Poland
[2] Jagiellonian Univ, Jagiellonian Ctr Expt Therapeut, Bobrzynskiego 14, PL-30348 Krakow, Poland
[3] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland
[4] Univ Missouri, Sch Med, Trauma Res Ctr, Dept Biomed Sci & Shock, Kansas City, MO 64108 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2019年 / 10期
关键词
MCPIP1; Peroxisome proliferator-activated receptor; gamma; TXNIP; Obesity; Fatty liver; PROTEIN-INDUCED PROTEIN-1; PPAR-GAMMA; IMPAIRS ADIPOGENESIS; FATTY-ACIDS; PGC-1-ALPHA; EXPRESSION; CELLS; DIFFERENTIATION; INFLAMMATION; LIPOGENESIS;
D O I
10.1016/j.bbalip.2019.06.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monocyte chemoattractant protein-l-induced protein-1 (MCPIP1) acts as an endonuclease that degrades selected mRNAs, viral RNAs and pre-miRNAs. MCPIP1 inhibits adipogenesis by degradation of C/EBP beta mRNA and adipogenesis-related miRNA, however its role in the regulation of hepatic lipid homeostasis is unknown. In this study, we investigated the role of MCPIP1 in the regulation of lipid metabolism in hepatocytes. C57BL/6 mice were fed a high-fat diet (HFD) for 2-20 weeks and next primary hepatocytes and adipose tissue were isolated. For in vitro experiments we used murine primary hepatocytes, control HepG2 cells and HepG2 with over-expressed or silenced MCPIP1. We found that Mcpip1 levels were lower in primary hepatocytes isolated from HFD-fed mice than in control cells starting at 4 weeks of a HFD. Level of Mcpip1 was also depleted in visceral fat isolated from obese and glucose-intolerant mice characterized by fatty liver disease. We showed that MCPIP1 overexpression in HepG2 cells treated with oleate induces the level and activity of peroxisome proliferator-activated receptor gamma (PPAR gamma). This phenotype was reverted upon silencing of MCPIP1 in HepG2 cells and in primary hepatocytes lacking MCPIP1 protein. MCPIP1 activated the PPAR gamma transcription factor via the thioredoxin-interacting protein (TXNIP)/peroxisome proliferator-activated receptor gamma coactivator 1- alpha (PGC-1 alpha) pathway. MCPIP1 contributes to lipid metabolism in hepatocytes by regulating the TXNIP/PGC-1 alpha/PPAR gamma pathway.
引用
收藏
页码:1458 / 1471
页数:14
相关论文
共 50 条
  • [31] The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome
    Kemanci, Aykut
    Goren, Tarik
    Uluturk, Mehmet
    Yilmaz, Atakan
    Sabirli, Ramazan
    Ozen, Mert
    Seyit, Murat
    Oskay, Alten
    Koseler, Aylin
    Turkcuer, Ibrahim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [32] Peroxisome proliferator-activated receptor gamma co-activator-1 alpha in depression and the response to electroconvulsive therapy
    Ryan, Karen M.
    Patterson, Ian
    McLoughlin, Declan M.
    PSYCHOLOGICAL MEDICINE, 2019, 49 (11) : 1859 - 1868
  • [33] Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons
    Makela, Johanna
    Tselykh, Timofey V.
    Kukkonen, Jyrki P.
    Eriksson, Ove
    Korhonen, Laura T.
    Lindholm, Dan
    NEUROPHARMACOLOGY, 2016, 102 : 266 - 275
  • [34] Role of peroxisome proliferator-activated receptor alpha and gamma in antiangiogenic effect of pomegranate peel extract
    Dana, Nasim
    Javanmard, Shaghayegh Haghjooy
    Rafiee, Laleh
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2016, 19 (01) : 106 - 110
  • [35] Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway
    Lin, Ching-Han
    Lee, Shang-Yu
    Zhang, Chun-Cheng
    Du, Ye-Fong
    Hung, Hao-Chang
    Wu, Hung-Tsung
    Ou, Horng-Yih
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3591 - 3597
  • [36] Peroxisome proliferator activated receptor α (PPARα) and PPAR gamma coactivator (PGC-1α) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements
    Song, Shulan
    Attia, Ramy R.
    Connaughton, Sara
    Niesen, Melissa I.
    Ness, Gene C.
    Elam, Marshall B.
    Hori, Roderick T.
    Cook, George A.
    Park, Edwards A.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 325 (1-2) : 54 - 63
  • [37] Peroxisome proliferator-activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
    Fumery, Mathurin
    Speca, Silvia
    Langlois, Audrey
    Davila, Anne-Marie
    Dubuquoy, Caroline
    Grauso, Marta
    Mena, Anthony Martin
    Figeac, Martin
    Metzger, Daniel
    Rousseaux, Christel
    Colombel, Jean-Frederic
    Dubuquoy, Laurent
    Desreumaux, Pierre
    Bertin, Benjamin
    EMBO MOLECULAR MEDICINE, 2017, 9 (11) : 1471 - 1481
  • [38] Ceramide induces apoptosis via a peroxisome proliferator-activated receptor γ-dependent pathway
    Wang, Jing
    Lv, Xiaowen
    Shi, Jieping
    Hu, Xiaosong
    APOPTOSIS, 2006, 11 (11) : 2043 - 2052
  • [39] A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies
    Pishvaian, Michael J.
    Marshall, John L.
    Wagner, Andrew J.
    Hwang, Jimmy J.
    Malik, Shakun
    Cotarla, Ion
    Deeken, John F.
    He, A. Ruth
    Daniel, Hirut
    Halim, Abdel-Baset
    Zahir, Hamim
    Copigneaux, Catherine
    Liu, Kejian
    Beckman, Robert A.
    Demetri, George D.
    CANCER, 2012, 118 (21) : 5403 - 5413
  • [40] Combination of Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Agonist and PPAR Gamma Co-Activator 1α (PGC-1α) Activator Ameliorates Cognitive Deficits, Oxidative Stress, and Inflammation in Rodent Model of Parkinson's Disease
    Das, Nihar Ranjan
    Vaidya, Bhupesh
    Khare, Pragyanshu
    Bishnoi, Mahendra
    Sharma, Shyam Sunder
    CURRENT NEUROVASCULAR RESEARCH, 2021, 18 (05) : 497 - 507